Additional COVID-19 Booster Shots? Officials Anticipate FDA Authorization Within Few Weeks

Vandana Singh
·1 min read
318

  • The U.S. Food and Drug Administration is reportedly moving toward authorizing a second round of omicron-targeted COVID-19 booster shots for the elderly and other people at high risk.

  • FDA officials could decide within a few weeks and could change their mind, Wall Street Journal reported citing the people close to the matter.

  • The deliberations come as some people especially vulnerable to infection have asked their doctors to give them a second round of the updated booster, even though the FDA hasn’t approved it.

  • Some infectious-disease experts have called on federal health officials to permit another booster shot to safeguard people with comparatively weaker immune defenses better, as the U.K. and Canada have done.

  • According to data from the CDC, people who get the shots are one-fourteenth as likely to die than unvaccinated people who didn’t get the updated shot.

  • Yet less than 17% of the total population have taken a second booster, compared with 69% who got the primary series, according to the CDC. 

  • About 40% of people 65 years and older have received the updated, dual-target shot below earlier levels.

  • In August, the FDA approved the bivalent COVID boosters targeting the BA.4 and BA.5 Omicron subvariants from Pfizer Inc (NYSE: PFE)/BioNTech SE (NASDAQ: BNTX) and Moderna Inc (NASDAQ: MRNA), along with the original strain.

  • Photo by Johaehn from Pixabay

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

This article Additional COVID-19 Booster Shots? Officials Anticipate FDA Authorization Within Few Weeks originally appeared on Benzinga.com

.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.